Dr. Ilva Rupenthal is an Associate Professor in the Department of Ophthalmology, University of Auckland, New Zealand, and the Director of the Buchanan Ocular Therapeutics Unit (BOTU), which aims to translate ocular therapeutic related scientific research into the clinical setting. She is currently a Humboldt Fellow with the Ocular Surface Group led by Professor Philipp Steven, Department of Ophthalmology, Universität zu Köln and Uniklinik Köln, investigating new therapeutics for ocular Graft-versus-Host Disease (oGvHD).
In her presentation, Ilva will give an overview of the research performed by the BOTU team focusing on the delivery of inflammasome blockers to treat inflammatory eye conditions. The talk will highlight various drug delivery approaches as well as preclinical models used to translate these ocular therapeutics from bench to bedside before outlining the rational for using an inflammasome blocker eyedrop to treat oGvHD.
Department of Ophthalmology – Building 34 – Lecture Hall